Nifty
Sensex
:
:
18338.55
61305.95
176.80 (0.97%)
568.90 (0.94%)

Pharmaceuticals & Drugs - Domestic

Rating :
45/99

BSE: 531349 | NSE: PANACEABIO

270.70
14-Oct-2021
  • Open
  • High
  • Low
  • Previous Close
  •  273.15
  •  278.00
  •  270.00
  •  268.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  120341
  •  328.17
  •  449.00
  •  170.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,657.75
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,341.48
  • N/A
  • -5.80

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.59%
  • 9.07%
  • 15.57%
  • FII
  • DII
  • Others
  • 0.02%
  • 0.00%
  • 1.75%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.27
  • 2.81
  • 11.01

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 9.95
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -3.04
  • 21.97
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -2.00
  • -5.65
  • 8.37

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.96
  • 15.80
  • 12.90

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Sep 20
Sep 19
Var%
Net Sales
132.45
132.76
-0.23%
168.27
125.36
34.23%
141.76
167.74
-15.49%
182.02
125.18
45.41%
Expenses
134.00
110.22
21.58%
167.33
148.23
12.89%
126.61
130.90
-3.28%
144.01
131.17
9.79%
EBITDA
-1.55
22.54
-
0.94
-22.87
-
15.15
36.84
-58.88%
38.01
-5.99
-
EBIDTM
-1.17%
16.98%
0.56%
-18.24%
10.69%
21.96%
20.88%
-4.79%
Other Income
3.23
1.19
171.43%
4.90
17.98
-72.75%
1.89
3.23
-41.49%
2.00
3.45
-42.03%
Interest
47.89
45.23
5.88%
46.91
44.46
5.51%
11.31
47.24
-76.06%
47.51
41.48
14.54%
Depreciation
11.06
11.33
-2.38%
11.58
10.05
15.22%
45.69
10.73
325.82%
11.38
11.08
2.71%
PBT
-57.27
-32.83
-
-52.65
-59.40
-
-39.96
-17.90
-
-18.88
-70.50
-
Tax
0.08
0.34
-76.47%
1.49
9.15
-83.72%
0.04
2.31
-98.27%
0.09
2.35
-96.17%
PAT
-57.35
-33.17
-
-54.14
-68.55
-
-40.00
-20.21
-
-18.97
-72.85
-
PATM
-43.30%
-24.98%
-32.17%
-54.68%
-28.22%
-12.05%
-10.42%
-58.20%
EPS
-9.36
-5.57
-
-8.83
-11.37
-
-6.53
-3.48
-
-3.15
-12.23
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
624.50
624.80
544.06
456.70
592.79
544.01
653.08
687.19
509.99
608.49
710.09
Net Sales Growth
13.33%
14.84%
19.13%
-22.96%
8.97%
-16.70%
-4.96%
34.75%
-16.19%
-14.31%
 
Cost Of Goods Sold
207.82
204.63
156.79
172.24
187.25
149.52
215.81
280.21
214.00
263.41
347.57
Gross Profit
416.68
420.17
387.27
284.45
405.55
394.50
437.27
406.98
295.99
345.08
362.52
GP Margin
66.72%
67.25%
71.18%
62.28%
68.41%
72.52%
66.96%
59.22%
58.04%
56.71%
51.05%
Total Expenditure
571.95
549.08
518.57
589.83
508.26
496.89
541.37
643.31
592.00
694.55
796.40
Power & Fuel Cost
-
30.94
29.74
34.55
33.52
30.55
25.15
30.73
31.74
37.76
29.26
% Of Sales
-
4.95%
5.47%
7.57%
5.65%
5.62%
3.85%
4.47%
6.22%
6.21%
4.12%
Employee Cost
-
156.25
144.42
147.08
151.59
148.12
142.02
135.98
144.92
146.94
160.72
% Of Sales
-
25.01%
26.54%
32.20%
25.57%
27.23%
21.75%
19.79%
28.42%
24.15%
22.63%
Manufacturing Exp.
-
43.22
33.38
44.31
40.05
41.88
39.47
43.97
52.69
67.15
50.82
% Of Sales
-
6.92%
6.14%
9.70%
6.76%
7.70%
6.04%
6.40%
10.33%
11.04%
7.16%
General & Admin Exp.
-
48.25
54.20
71.07
40.39
52.98
39.41
56.82
60.39
73.47
75.49
% Of Sales
-
7.72%
9.96%
15.56%
6.81%
9.74%
6.03%
8.27%
11.84%
12.07%
10.63%
Selling & Distn. Exp.
-
51.18
42.81
31.27
36.98
37.70
44.20
44.20
46.09
48.87
57.65
% Of Sales
-
8.19%
7.87%
6.85%
6.24%
6.93%
6.77%
6.43%
9.04%
8.03%
8.12%
Miscellaneous Exp.
-
14.60
57.24
89.31
18.48
36.14
35.31
51.40
42.17
56.95
57.65
% Of Sales
-
2.34%
10.52%
19.56%
3.12%
6.64%
5.41%
7.48%
8.27%
9.36%
10.55%
EBITDA
52.55
75.72
25.49
-133.13
84.53
47.12
111.71
43.88
-82.01
-86.06
-86.31
EBITDA Margin
8.41%
12.12%
4.69%
-29.15%
14.26%
8.66%
17.11%
6.39%
-16.08%
-14.14%
-12.15%
Other Income
12.02
10.57
30.35
5.06
8.23
46.59
20.35
28.48
15.36
5.44
8.83
Interest
153.62
185.34
173.98
104.83
100.58
100.93
127.33
104.53
150.30
103.76
100.71
Depreciation
79.71
46.07
44.13
55.03
58.53
67.95
73.32
67.24
71.10
85.99
77.13
PBT
-168.76
-145.11
-162.28
-287.93
-66.35
-75.17
-68.59
-99.41
-288.05
-270.37
-255.32
Tax
1.70
2.63
16.95
8.56
9.86
-10.98
1.92
3.08
1.68
-18.76
-54.19
Tax Rate
-1.01%
-1.81%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
-1.51%
7.41%
21.22%
PAT
-170.46
-147.78
-194.60
37.58
-74.18
-54.75
-18.51
-100.70
-111.56
-234.30
-201.13
PAT before Minority Interest
-170.46
-147.74
-194.63
37.52
-76.20
-56.47
-20.85
-102.49
-112.64
-234.30
-201.13
Minority Interest
0.00
-0.04
0.03
0.06
2.02
1.72
2.34
1.79
1.08
0.00
0.00
PAT Margin
-27.30%
-23.65%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
-21.87%
-38.51%
-28.32%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-27.81
-24.11
-31.75
6.13
-12.10
-8.93
-3.02
-16.43
-18.20
-38.22
-32.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
-228.69
198.79
350.40
308.68
355.68
448.61
471.29
512.72
625.69
875.12
Share Capital
6.13
6.13
6.13
6.13
6.13
22.43
22.43
6.13
6.13
6.13
Total Reserves
-234.82
160.66
344.27
302.55
349.55
426.18
448.76
506.59
619.56
868.99
Non-Current Liabilities
984.70
740.66
70.08
591.13
718.78
1,100.11
918.47
767.07
865.20
720.28
Secured Loans
675.25
583.55
8.90
560.45
704.57
866.08
721.77
581.77
688.31
509.82
Unsecured Loans
59.83
29.58
37.22
10.26
9.49
1.00
1.20
1.40
1.60
2.70
Long Term Provisions
55.36
42.74
39.78
26.54
18.36
184.42
180.43
180.47
171.27
170.81
Current Liabilities
595.85
622.14
938.26
695.52
689.13
474.80
706.03
826.82
509.96
516.52
Trade Payables
221.94
198.85
269.71
277.19
248.60
187.87
209.13
252.11
175.69
122.21
Other Current Liabilities
189.06
242.12
585.25
242.00
237.52
93.60
194.85
251.91
49.82
134.72
Short Term Borrowings
0.00
3.57
69.39
164.88
190.71
191.82
295.84
320.67
274.00
249.54
Short Term Provisions
184.85
177.60
13.92
11.44
12.30
1.51
6.21
2.13
10.45
10.05
Total Liabilities
1,348.86
1,558.55
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
2,118.52
Net Block
608.70
657.39
805.56
948.97
1,001.37
1,071.11
1,144.30
1,275.54
1,154.49
1,195.10
Gross Block
1,261.62
1,282.22
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
1,697.63
1,694.13
1,638.61
Accumulated Depreciation
652.92
624.84
587.34
656.87
598.70
549.18
489.18
422.09
539.64
443.51
Non Current Assets
837.89
875.27
847.84
1,027.55
1,070.91
1,475.22
1,573.49
1,739.28
1,574.45
1,617.03
Capital Work in Progress
34.42
24.01
22.51
39.92
30.41
115.78
110.31
116.55
135.26
90.83
Non Current Investment
0.07
5.58
5.33
5.25
7.01
5.19
10.20
15.97
16.51
30.91
Long Term Loans & Adv.
189.09
187.70
13.33
28.01
22.03
236.71
262.44
274.94
266.34
293.65
Other Non Current Assets
5.61
0.60
1.12
5.39
10.09
1.26
1.07
0.35
1.85
6.54
Current Assets
510.97
683.27
507.89
564.83
703.22
549.38
525.72
372.81
433.75
501.49
Current Investments
0.00
0.00
0.00
2.03
0.27
3.52
4.98
0.00
5.99
1.60
Inventories
174.14
147.69
81.43
334.21
315.55
305.24
310.22
219.81
267.94
385.26
Sundry Debtors
84.68
68.52
88.73
136.01
142.17
141.67
98.57
94.93
69.86
68.38
Cash & Bank
135.79
89.75
23.48
23.24
14.13
22.93
52.40
24.78
39.23
15.51
Other Current Assets
116.36
335.69
273.23
10.06
231.09
76.02
59.55
33.29
50.73
30.74
Short Term Loans & Adv.
63.72
41.62
41.02
59.30
56.21
66.76
50.15
24.72
44.44
19.33
Net Current Assets
-84.88
61.13
-430.38
-130.69
14.08
74.58
-180.31
-454.01
-76.21
-15.03
Total Assets
1,348.86
1,558.54
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
2,118.52

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
106.76
-30.47
104.80
118.02
130.67
90.69
37.23
53.73
-24.02
228.09
PBT
-145.03
-177.34
46.23
-66.14
-67.18
-18.93
-99.41
-110.96
-253.06
-255.32
Adjustment
230.88
253.04
-70.58
166.62
149.57
148.75
167.45
59.92
161.18
200.35
Changes in Working Capital
21.91
-97.50
127.32
21.45
43.32
-58.26
-25.16
107.22
68.23
287.84
Cash after chg. in Working capital
107.76
-21.80
102.97
121.93
125.71
71.56
42.88
56.18
-23.65
232.87
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.00
-8.67
1.83
-3.91
4.96
19.13
-5.65
-2.45
-0.37
-4.78
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-47.68
-34.76
-5.27
55.29
-25.83
16.44
-37.38
-37.60
-61.19
-123.91
Net Fixed Assets
32.78
223.59
488.74
-15.06
-27.48
11.93
-29.48
-5.26
-31.39
-481.95
Net Investments
-11.55
-51.99
342.34
0.00
49.78
0.00
-0.46
-122.35
-13.38
-25.53
Others
-68.91
-206.36
-836.35
70.35
-48.13
4.51
-7.44
90.01
-16.42
383.57
Cash from Financing Activity
-47.11
90.74
-101.14
-164.35
-106.96
-117.38
-0.70
-30.26
104.89
-133.63
Net Cash Inflow / Outflow
11.97
25.51
-1.61
8.97
-2.13
-10.25
-0.85
-14.13
19.68
-29.45
Opening Cash & Equivalents
40.22
14.47
16.44
7.47
9.59
19.97
20.84
34.95
15.16
44.26
Closing Cash & Equivalent
52.08
40.22
14.47
16.44
7.47
9.73
19.99
20.84
34.95
15.16

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
-37.34
27.23
57.21
50.40
58.07
-4.43
-0.75
13.96
34.08
72.93
ROA
-10.16%
-13.36%
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
-5.47%
-11.36%
-10.44%
ROE
0.00%
-75.26%
11.39%
-22.94%
-34.38%
0.00%
-253.03%
-76.49%
-71.43%
-36.53%
ROCE
5.25%
-0.38%
13.44%
2.63%
2.76%
9.93%
0.45%
3.37%
-11.89%
-10.89%
Fixed Asset Turnover
0.49
0.41
0.30
0.37
0.35
0.40
0.41
0.30
0.37
0.53
Receivable days
44.75
52.75
89.81
85.16
92.84
67.10
51.36
58.89
41.39
88.28
Inventory Days
94.00
76.86
166.09
198.91
203.06
171.89
140.68
174.32
195.55
204.27
Payable days
143.26
178.20
213.56
186.55
163.89
130.73
137.37
148.94
82.64
57.15
Cash Conversion Cycle
-4.51
-48.60
42.34
97.52
132.00
108.26
54.67
84.27
154.30
235.40
Total Debt/Equity
-3.58
4.45
1.85
3.05
2.79
-100.22
93.42
12.38
4.69
1.96
Interest Cover
0.22
-0.02
1.44
0.34
0.33
0.85
0.05
0.26
-1.44
-1.54

News Update:


  • Panacea Biotec supplies first shipment of second component of Sputnik V vaccine produced in India
    7th Sep 2021, 09:28 AM

    This is the first batch of the second component produced and supplied by the company in India

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.